Morningside Pharmaceuticals Ltd has once again been named as one of the 200 fastest growing companies in the East Midlands.

Professional services network Grant Thornton provides the annual report, which highlights the top performing businesses in Leicestershire, Derbyshire, Nottinghamshire and Lincolnshire.

Dr Nik Kotecha OBE, Chief Executive Officer of Morningside Pharmaceuticals said: “We are immensely proud to be recognised as one of the fastest growing companies in the East Midlands.

“We would not have achieved this without a dedicated team of professions who place great emphasis on making quality healthcare an affordable and accessible reality throughout the world.

“We are constantly investing in research & development and have created a well-established branded and generic medicines portfolio for NHS and international supply. We pride ourselves on the ability to change rapidly and respond to the market and our customers.

“Another key factor that has helped drive growth is our focus on improving our logistics and distribution network. We work closely with our customers to ensure accurate and on-time delivery in the UK and international markets.”

The East Midlands Top 200 have grown their profits by an average of 35% this year, together providing 48,000 jobs, which is an 8% increase in 3 years.

Mark Pashley, from Grant Thornton, said: “We are delighted to report that this year there are over a third of the Top 200 who appeared in last year’s list. This is not an easy achievement and shows that the attitude to sustainable growth is important to bring through financial rewards.

“The greatest opportunity for the East Midlands is in relation to its economic performance, both in terms of creating wealth and jobs, as well as having an entrepreneurial skills set to drive future growth.

“Overall the East Midlands continues to perform strongly in terms of business growth compared to the rest of the UK.”

To find out more about Morningside Pharmaceuticals, please click here.

Latest Opportunities

Exporting Starts Here programme for West Midlands companies

West Midlands Combined Authority (WMCA), funded by the UK Shared Prosperity Fund (UKSPF), has commissioned…

NIHR i4i Connect funding call

The NIHR Invention for Innovation (i4i) programme is accepting outline applications to their latest researcher-led Connect funding…

Study brief: The effects of a recovery gel on endurance cycling performance in the heat

The popularity of endurance sports like cycling and running has grown significantly over the past…

Latest News

Blog: Why cleanrooms are essential for medical-grade cannabis companies

By Medilink Midlands Member Airology Systems The demand for medical-grade cannabis has surged in recent…

Australia’s Cannim partners with PHTA to advance medicinal cannabis research

Leading medicinal cannabis company Cannim has announced its UK operations will be based at Birmingham’s…

New sleep trial shows dramatic benefits for participants

Cambridge Sleep Sciences (CSS), a leading UK innovator in sleep technology, has announced groundbreaking results…